You will be responsible for the early clinical development strategy, up to and including Clinical Proof of Concept within Cognition Disorder discover, research and development. You will provide expert input into the identification of surrogate markers, bio-markers or endpoints to be used in clinical trials.

The Director Neurodegeneration will be responsible for leading a team of expert scientists for the continued understanding and development of molecular mechanisms of Neurodegeneration, ideally with expertise within Alzheimer’s disease and Parkinson’s disease.

Join a highly entrepreneurial business in a strategic role as they seek to bring a innovative approach to clinical trial patient recruitment with the development of a unique search engine, platform and methodology.

Reporting to the Practice Leader you will play a crucial role in the continued strategic development and direction of the business, delivering quality solutions and enhancing your and the company’s Subject Matter Expertise.

Reporting to the General Manager (Singapore) you will play a crucial role in the continued development, management and leadership of this state of the art in vivo / ex vivo facility. This operation is focused on the development of novel and scientifically robust approaches that provide reliable scientific evidence and data, of the highest quality, using a systems biology-based approach. This helps us to understand mechanisms of disease observed in animal models and then translate these observations to human physiology – validating scientific concepts and developing new tools for future research.